Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium’s position statement, American Journal of Transplantation, March 2019, Elsevier,
DOI: 10.1111/ajt.15214.
You can read the full text:

Read

Contributors

The following have contributed to this page